- Home
- AWX vs BCLI Comparison
AWX vs BCLI Comparison
Compare AWX & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AWX
- BCLI
- Stock Information
- Founded
- AWX 1998
- BCLI 2000
- Country
- AWX United States
- BCLI United States
- Employees
- AWX N/A
- BCLI N/A
- Industry
- AWX Environmental Services
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AWX Utilities
- BCLI Health Care
- Exchange
- AWX Nasdaq
- BCLI Nasdaq
- Market Cap
- AWX 13.6M
- BCLI 9.9M
- IPO Year
- AWX 1998
- BCLI N/A
- Fundamental
- Price
- AWX $3.56
- BCLI $1.73
- Analyst Decision
- AWX
- BCLI Strong Buy
- Analyst Count
- AWX 0
- BCLI 1
- Target Price
- AWX N/A
- BCLI $30.00
- AVG Volume (30 Days)
- AWX 9.7K
- BCLI 41.1K
- Earning Date
- AWX 03-20-2025
- BCLI 03-31-2025
- Dividend Yield
- AWX N/A
- BCLI N/A
- EPS Growth
- AWX N/A
- BCLI N/A
- EPS
- AWX 0.25
- BCLI N/A
- Revenue
- AWX $83,487,000.00
- BCLI N/A
- Revenue This Year
- AWX N/A
- BCLI N/A
- Revenue Next Year
- AWX N/A
- BCLI N/A
- P/E Ratio
- AWX $14.09
- BCLI N/A
- Revenue Growth
- AWX N/A
- BCLI N/A
- 52 Week Low
- AWX $2.00
- BCLI $1.05
- 52 Week High
- AWX $3.99
- BCLI $11.85
- Technical
- Relative Strength Index (RSI)
- AWX 47.80
- BCLI 40.62
- Support Level
- AWX $3.21
- BCLI $1.69
- Resistance Level
- AWX $3.72
- BCLI $1.93
- Average True Range (ATR)
- AWX 0.22
- BCLI 0.11
- MACD
- AWX -0.01
- BCLI -0.00
- Stochastic Oscillator
- AWX 38.67
- BCLI 16.67
About AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.